臺大學術典藏 |
2018-09-10T06:49:08Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie, W.-C.;Li, C.-Y.;Huang, C.-S.;Chang, K.-J.;Yen, M.-L.;Lin, R.-S.; MEN-LUH YEN; WEI-CHU CHIE |
臺大學術典藏 |
2018-09-10T07:12:47Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie, W.-C.; Li, C.-Y.; Huang, C.-S.; Chang, K.-J.; Yen, M.-L.; Lin, R.-S.; CHIUN-SHENG HUANG |
臺大學術典藏 |
2020-02-11T01:34:22Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
MEN-LUH YEN;Lin R.-S.;Chang K.-J;Huang C.-S;Li C.-Y;Chie W.-C; Chie W.-C; Li C.-Y; Huang C.-S; Chang K.-J; MEN-LUH YEN; Lin R.-S. |
臺大學術典藏 |
1998 |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Lin R.-S.; Yen M.-L.; Chang K.-J.; Li C.-Y.; CHIUN-SHENG HUANG; Chie W.-C.; Lin R.-S.;Yen M.-L.;Chang K.-J.;CHIUN-SHENG HUANG;Li C.-Y.;Chie W.-C. |
臺大學術典藏 |
2022-05-05T09:10:42Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
WEI-CHU CHIE; Li C.-Y.; Huang C.-S.; Chang K.-J.; Yen M.-L.; Lin R.-S. |
臺大學術典藏 |
2022-08-12T06:29:05Z |
Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives
|
Chie W.-C.; Li C.-Y.; Huang C.-S.; KING-JEN CHANG; Yen M.-L.; Lin R.-S. |
臺大學術典藏 |
2022-05-14T23:35:19Z |
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
|
Hsieh, Cho Hsun; Huang, Yi Wei; TSEN-FANG TSAI |
臺大學術典藏 |
2022-09-20T06:06:16Z |
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
|
Hsieh, Cho-Hsun; Huang, Yi-Wei; TSEN-FANG TSAI |
輔英科技大學 |
2013-03-01 |
Oral Corrective Feedback---Impolicit or Explicit?
|
胡娟暐 |
輔英科技大學 |
2013-03-08 |
Oral Corrective Feedback--Implicit or Explicit?
|
魏孟雪 |
國立成功大學 |
2021 |
Oral corticosteroid bursts and severe adverse events: a critical appraisal
|
Shao, Shao S.-C.;Kuo, L.-T.;Lai, E.C.C.;Chi, Chi C.-C. |
臺大學術典藏 |
2017 |
Oral delivery of dsRNA lipoplexes to German cockroach protects dsRNA from degradation and induces RNAi response
|
Lin Y.-H.; Huang J.-H.; Liu Y.; Belles X.; Lee H.-J.; HOW-JING LEE |
國家衛生研究院 |
2008-06 |
Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation
|
Mi, FL; Wu, YY; Lin, YH; Sonaje, K; Ho, YC; Chen, CT; Juang, JH; Sung, HW |
中國醫藥大學 |
2008.06 |
Oral Delivery of Peptide Drugs Using Nanoparticles Self-Assembled by Poly(γ-glutamic acid) and a Chitosan Derivative Functionalized by Trimethylation
|
糜福隆(Fwu-Long Mi); 吳勇毅(Yong-Yi Wu); 林宥欣(Yu-Hsin. Lin); (Kiran Sonaje); (Yi-Cheng Ho); 陳炯東(Chiung-Tong Chen); 莊峻鍠(Jyuhn-Huarng Juang); 宋信文(Hsing-Wen Sung)* |
國立成功大學 |
2022-02 |
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
|
Lo, Ching-Lung;Syue, Ling-Shan;Ko, Wen-Chien |
中山醫學大學 |
2017-06 |
Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype
|
Lee, Shou-Wu;Yang, Sheng-Shun;Lee, Teng-Yu;Yeh, Hong-Zen;Lu, I-Ta;Chang, Chi-Sen |
臺大學術典藏 |
2020-10-22T07:27:40Z |
Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review
|
Tsai Y.C.;Tsen-Fang Tsai; Tsai Y.C.; TSEN-FANG TSAI |
國立臺灣科技大學 |
2009-02 |
Oral English from the Politeness Perspective--A Case Study
|
Jil;江瑞菁 |
臺大學術典藏 |
2020-03-24T03:48:05Z |
Oral Fluoroquinolone and the Risk of Aortic Dissection
|
Chang S.-S.; Lee S.-H.; Lee W.-C.; Porta L.; Hsieh R.; Lee M.-T.G.; Chang S.-S.;Lee S.-H.;Lee W.-C.;Porta L.;Hsieh R.;Lee M.-T.G.;CHIEN-CHANG LEE; CHIEN-CHANG LEE |
臺大學術典藏 |
2020-12-16T08:52:14Z |
Oral Fluoroquinolone and the Risk of Aortic Dissection
|
Chien-Chang Lee;Lee M.-T.G.;Hsieh R.;Porta L.;Lee W.-C.;Lee S.-H.;Chang S.-S.; CHIEN-CHANG LEE; Lee M.-T.G.; Hsieh R.; Porta L.; Lee W.-C.; Lee S.-H.; Chang S.-S. |
臺大學術典藏 |
2019-03-08T07:58:01Z |
Oral Fluoroquinolone and the Risk of Aortic Dissection
|
Chang, Shy-Shin; Lee, Si-Huei; Lee, Wan-Chien; Porta, Lorenzo; Hsieh, Ronan; Lee, Meng-Tse Gabriel; CHIEN-CHANG LEE; Chien-Chang Lee;Lee, Meng-Tse Gabriel;Hsieh, Ronan;Porta, Lorenzo;Lee, Wan-Chien;Lee, Si-Huei;Chang, Shy-Shin |
臺大學術典藏 |
2019-03-08T08:07:05Z |
Oral Fluoroquinolone and the Risk of Aortic Dissection
|
Chang, Shy-Shin;Lee, Si-Huei;Lee, Wan-Chien;Porta, Lorenzo;Hsieh, Ronan;Lee, Meng-Tse Gabriel;CHIEN-CHANG LEE; CHIEN-CHANG LEE; Lee, Meng-Tse Gabriel; Hsieh, Ronan; Porta, Lorenzo; Lee, Wan-Chien; Lee, Si-Huei; Chang, Shy-Shin |
中山醫學大學 |
2015 |
Oral fungal immunomodulatory protein-Flammulina velutipes has influence on pulmonary inflammatory process and potential treatment for allergic airway disease: A mouse model
|
PY, Chu; HL, Sun; JL, Ko; MS, Ku; LJ, Lin; YT, Lee; PF, Liao; HH, Pan; HL, Lu; KH, Lue |
中山醫學大學 |
2017 |
Oral fungal immunomodulatory protein-Flammulina velutipes has influence on pulmonary inflammatory process and potential treatment for allergic airway disease: A mouse model
|
Chu, P.-Y.;Sun, H.-L.;Ko, J.-L.;Ku, M.-S.;Lin, Lin L.-J.;Lee, Y.-T.;Liao, P.-F.;Pan, H.-H.;Lu, H.-L.;Lue, K.-H. |
臺大學術典藏 |
2021-05-06T01:53:09Z |
Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains
|
Chang S.-C.; Hsieh S.-M.; Chen M.-L.; Sheng W.-H.; YEE-CHUN CHEN |